Lb Pharmaceuticals IncLBRX
Price (close)
$37.80
Market cap
—
P/E
—
Revenue (TTM)
—
Net income
-$85.7M
Dividend yield
—
1-year total return
152.8%
Net margin
—
Revenue growth
—
Debt / equity
—
What Lb Pharmaceuticals Inc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net income | — | -$63.1M | -$25.2M |
| Free cash flow | — | -$53.8M | -$35.3M |
More on LBRX.
- Lb Pharmaceuticals Inc summary
- Lb Pharmaceuticals Inc financial statements
- Lb Pharmaceuticals Inc key metrics
- Lb Pharmaceuticals Inc health scores and style box
- Lb Pharmaceuticals Inc earnings
- Lb Pharmaceuticals Inc dividends
- Lb Pharmaceuticals Inc valuation
- Lb Pharmaceuticals Inc ownership and insiders
- Lb Pharmaceuticals Inc peers
Figures from Lb Pharmaceuticals Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.